small cerebral vascular disease complicated with insomnia
Conditions
Interventions
Control group:Cognitive Behavioral Therapy for Insomnia
experimental group:Acupuncture and Cognitive Behavioral Therapy for Insomnia
Sponsors
the People's Hospital Affiliated to Fujian University of Traditional Chinese Medicine
Eligibility
Sex/Gender
All
Age
45 Years to 75 Years
Inclusion criteria
Inclusion criteria: 1. It also fulfilled the diagnostic criteria for cognitive dysfunction and insomnia in small cerebral vascular disease. 2. Male and female patients aged 45 to 75. 3. Years of education above 8 years or at the junior high school education level and above. 4. PSQI score ranging from 7 to 15 points MoCA score ranging from 19 to 25 points. 5. The patient voluntarily participated in this study and had not received treatment related to other subjects within nearly 1 month. 6. The informed consent was signed by the patient himself or by his immediate family members.
Exclusion criteria
Exclusion criteria: Presence of other imaging changes or diseases sufficient to explain memory or other cognitive impairments including: non-cavitary infarctions in both cortical and subcortical regions cerebral hemorrhage; specific causes of white matter changes (e.g. multiple sclerosis tuberous sclerosis brain radiotherapy); brain lesions (such as Alzheimer's disease Lewy body dementia frontotemporal dementia Parkinson's disease tumors hydrocephalus trauma syphilis acquired immunodeficiency syndrome Creutzfeldt-Jakob disease etc.); severe psychiatric disorders and epilepsy substance abuse (including alcohol) poisoning and metabolic abnormalities; significant anxiety depression affective disorders schizophrenia and other severe mental disorders; current or recent (within the past week) use of benzodiazepine receptor agonists (BzRAs) or melatonin receptor agonists (such as ramelteon) and sedative antidepressants (such as trazodone mirtazapine fluvoxamine and dosulepin); dependency on the aforementioned medications requiring a daily dosage exceeding two tablets with difficulty in discontinuation; primary insomnia patients with a duration of more than ten years; individuals with a fear of needles or coagulation disorders that prevent them from undergoing acupuncture treatment; women who are currently breastfeeding or pregnant or those with recent intentions to conceive.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Pittsburgh Sleep Quality Index Scale; | — |
Secondary
| Measure | Time frame |
|---|---|
| Montreal Cognitive Assessment Scale;Serum irisin; | — |
Countries
China
Contacts
Public ContactChen Yifan
The Peoples Hospital Affiliated of Fujian University of Traditional Chinese Medicine
Outcome results
None listed